AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 250: F32-F39, 1986;
0363-6127/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. E.
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. E.
Right arrow Articles by Granger, J. P.

AJP - Renal Physiology, Vol 250, Issue 1 32-F39, Copyright © 1986 by American Physiological Society


ARTICLES

Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs

J. E. Hall and J. P. Granger

The major aim of this study was to examine the chronic effects of increased intrarenal adenosine (ADO) levels on control of renal hemodynamics and mean arterial pressure (MAP). In six uninephrectomized conscious dogs, intrarenal ADO infusion (2 micrograms . kg-1 . min-1) for 6 days caused no significant changes in MAP, which averaged 94 +/- 3 mmHg during the control period and 91 +/- 2 mmHg during ADO infusion. ADO infusion for 6 days decreased glomerular filtration rate (GFR) and filtration fraction while causing no significant changes in effective renal plasma flow (ERPF) or sodium and water balance. To examine the role of angiotensin II (ANG II) in altering the blood pressure and renal effects of ADO, we also studied the effects of intrarenal ADO infusion in five uninephrectomized conscious dogs during continuous intrarenal infusion of ANG II (1 ng . kg-1 . min-1) to prevent renal levels of ANG II from decreasing. However, even when renal ANG II levels were maintained constant, ADO infusion at 2 micrograms . kg-1 . min-1 for 4 days and 10 micrograms . kg-1 . min-1 for 5 days failed to alter MAP, which averaged 104 +/- 6 mmHg during the control period, 106 +/- 5 mmHg during infusion of 2 micrograms . kg-1 . min-1, and 105 +/- 5 mmHg during infusion of 10 micrograms. . kg-1 . min-1 ADO. Intrarenal ANG II infusion did not prevent decreases in GFR and filtration fraction during ADO infusion.(ABSTRACT TRUNCATED AT 250 WORDS)





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online